Monitoring Organ Donors to Increase Transplantation Results (MOnIToR)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

556 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-08-31

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to determine whether protocol guided resuscitation of brain dead organ donors using Pulse Pressure Variation (PPV) will increase the number of organs transplanted per donor.

Specifically the study aims to:

1. improve resuscitation of potential organ donors.
2. improve organ function in donors.
3. increase organ recovery per donor.

The investigators will randomize 960 subjects to either protocolized resuscitation (n=480) using a consensus-based PPV-guided algorithm or usual care using a 1:1 randomization scheme. The primary outcome is the mean number of organs transplanted per donor. Secondary outcomes include 6mHFS (six-month hospital-free survival) in the recipients, and mean number of organs procured per donor that are suitable for transplantation (intention to transplant). The study is powered to detect a 0.5 organ increase for transplantation per donor.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time

NCT06874296

Liver Transplantation Liver Diseases Surgery

RECRUITING NA

Remote Ischemic Preconditioning In Abdominal Organ Transplantation

NCT00975702

Kidney Disease Liver Disease Pancreas Disease

COMPLETED PHASE3

Pilot Study to Assess Safety and Feasibility of Normothermic Machine Preservation In Human Liver Transplantation

NCT02515708

Liver Transplantation

COMPLETED NA

Heart Transplantation Utilizing NRP DCD

NCT05243914

Heart Transplantation Perfusion Transplant Recipients

TERMINATED

Immunometabolism of Machine Perfusion Strategies

NCT06371924

Liver Transplantation

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transplantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Protocolized Care

Algorithm to manage Pulse Pressure Variation, Cardiac Index, and Mean Arterial Pressure will be used in these donors.

Group Type EXPERIMENTAL

Protocolized care

Intervention Type PROCEDURE

Organ Procurement Coordinators will utilize a hemodynamic monitor and algorithm for donor management of cardiac index, pulse pressure variation and mean arterial pressure.

Standard Care

This is the Organ Procurement Organization current practices.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Protocolized care

Organ Procurement Coordinators will utilize a hemodynamic monitor and algorithm for donor management of cardiac index, pulse pressure variation and mean arterial pressure.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Donors who were declared brain dead per local hospital brain death criteria.
* Donors who are deemed suitable for organ donation by the local OPO whether they meet the standard criteria or the extended criteria for donation.
* Presence of functioning arterial catheter.

Exclusion Criteria

* Inability to obtain informed consent from donor next of kin or legal representative.
* Donors less than 16 years of age, no maximum age limit.
* Inability to perform hemodynamic monitoring.
* Patients on lithium therapy prior to brain death.
* Known severe aortic regurgitation, intra-cardiac shunts, or on intra-aortic balloon pump.
* Donors previously enrolled in experimental protocol in which cytokines are the therapeutic targets (e.g. anti-TNF antibodies).
* Donors receiving chemotherapy or with any disease state (e.g. AIDS) that renders the subject leukopenic (WBC count \< 2).
* Donors receiving anti-leukocyte drugs (e.g. OKT3) regardless of their WBC counts.
* Pregnant donors.
* Donor is on ECMO machine

Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No